Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia.
Lamiquiz-Moneo I, Restrepo-Córdoba MA, Mateo-Gallego R, Bea AM, Del Pino Alberiche-Ruano M, García-Pavía P, Cenarro A, Martín C, Civeira F, Sánchez-Hernández RM. Atherosclerosis. 2020 Jan; 292:143-151. Epub 2019 Nov 29.